Literature DB >> 18665448

Intravital imaging of CD8+ T cell function in cancer.

Thorsten R Mempel1, Christian A Bauer.   

Abstract

Recent technological advances in photonics are making intravital microscopy (IVM) an increasingly powerful approach for the mechanistic exploration of biological processes in the physiological context of complex native tissue environments. Direct, dynamic and multiparametric visualization of immune cell behavior in living animals at cellular and subcellular resolution has already proved its utility in auditing basic immunological concepts established through conventional approaches and has also generated new hypotheses that can conversely be complemented and refined by traditional experimental methods. The insight that outgrowing tumors must not necessarily have evaded recognition by the adaptive immune system, but can escape rejection by actively inducing a state of immunological tolerance calls for a detailed investigation of the cellular and molecular mechanisms by which the anti-cancer response is subverted. Along with molecular imaging techniques that provide dynamic information at the population level, IVM can be expected to make a critical contribution to this effort by allowing the observation of immune cell behavior in vivo at single cell-resolution. We review here how IVM-based investigation can help to clarify the role of cytotoxic T lymphocytes (CTL) in the immune response against cancer and identify the ways by which their function might be impaired through tolerogenic mechanisms.

Entities:  

Mesh:

Year:  2008        PMID: 18665448      PMCID: PMC3747036          DOI: 10.1007/s10585-008-9196-9

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  165 in total

Review 1.  Principles of two-photon excitation microscopy and its applications to neuroscience.

Authors:  Karel Svoboda; Ryohei Yasuda
Journal:  Neuron       Date:  2006-06-15       Impact factor: 17.173

2.  Extrafollicular activation of lymph node B cells by antigen-bearing dendritic cells.

Authors:  Hai Qi; Jackson G Egen; Alex Y C Huang; Ronald N Germain
Journal:  Science       Date:  2006-06-16       Impact factor: 47.728

3.  Modulation of dendritic cell function by naive and regulatory CD4+ T cells.

Authors:  Marc Veldhoen; Halima Moncrieffe; Richard J Hocking; Christopher J Atkins; Brigitta Stockinger
Journal:  J Immunol       Date:  2006-05-15       Impact factor: 5.422

Review 4.  Rulers over randomness: stroma cells guide lymphocyte migration in lymph nodes.

Authors:  Thorsten R Mempel; Tobias Junt; Ulrich H von Andrian
Journal:  Immunity       Date:  2006-12       Impact factor: 31.745

5.  In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor.

Authors:  Alexandre Boissonnas; Luc Fetler; Ingrid S Zeelenberg; Stéphanie Hugues; Sebastian Amigorena
Journal:  J Exp Med       Date:  2007-01-29       Impact factor: 14.307

6.  CC chemokine receptor 7 contributes to Gi-dependent T cell motility in the lymph node.

Authors:  Takaharu Okada; Jason G Cyster
Journal:  J Immunol       Date:  2007-03-01       Impact factor: 5.422

Review 7.  Regulatory T cells, tumour immunity and immunotherapy.

Authors:  Weiping Zou
Journal:  Nat Rev Immunol       Date:  2006-04       Impact factor: 53.106

Review 8.  A central role for central tolerance.

Authors:  Bruno Kyewski; Ludger Klein
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

Review 9.  Cancer immunosurveillance, immunoediting and inflammation: independent or interdependent processes?

Authors:  Jack D Bui; Robert D Schreiber
Journal:  Curr Opin Immunol       Date:  2007-02-09       Impact factor: 7.486

10.  Dynamic imaging of dendritic cell extension into the small bowel lumen in response to epithelial cell TLR engagement.

Authors:  Marcello Chieppa; Maria Rescigno; Alex Y C Huang; Ronald N Germain
Journal:  J Exp Med       Date:  2006-12-04       Impact factor: 14.307

View more
  13 in total

Review 1.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

Review 2.  Trafficking of immune cells in the central nervous system.

Authors:  Emma H Wilson; Wolfgang Weninger; Christopher A Hunter
Journal:  J Clin Invest       Date:  2010-05-03       Impact factor: 14.808

Review 3.  Dynamic imaging of cancer invasion and metastasis: principles and preclinical applications.

Authors:  Peter Friedl
Journal:  Clin Exp Metastasis       Date:  2009       Impact factor: 5.150

4.  Toll-like receptor agonist rMBP-NAP enhances antitumor cytokines production and CTL activity of peripheral blood mononuclear cells from patients with lung cancer.

Authors:  Cong Ding; Li Li; Yi Zhang; Zhenyu Ji; Chenglong Zhang; Taotao Liang; Xun Guo; Xin Liu; Qiaozhen Kang
Journal:  Oncol Lett       Date:  2018-07-20       Impact factor: 2.967

5.  Regulatory T Cells: Concept, Classification, Phenotype, and Biological Characteristics.

Authors:  Yang Du; Qiannan Fang; Song-Guo Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 6.  T cells in tumor microenvironment.

Authors:  Yağmur Kiraz; Yusuf Baran; Ayten Nalbant
Journal:  Tumour Biol       Date:  2015-10-18

7.  TLR agonist rMBP-NAP inhibits B16 melanoma tumor growth via induction of DCs maturation and T-cells cytotoxic response.

Authors:  Jiaojiao Liu; Cong Ding; Xiaolong Wang; Lu Yang; Xin Liu; Qiaozhen Kang
Journal:  Cytotechnology       Date:  2022-07-02       Impact factor: 2.040

Review 8.  Intravital imaging of stromal cell dynamics in tumors.

Authors:  Marja Lohela; Zena Werb
Journal:  Curr Opin Genet Dev       Date:  2009-11-26       Impact factor: 5.578

9.  The tumor microenvironment: a pitch for multiple players.

Authors:  Giovanna Schiavoni; Lucia Gabriele; Fabrizio Mattei
Journal:  Front Oncol       Date:  2013-04-17       Impact factor: 6.244

10.  Substantially modified ratios of effector to regulatory T cells during chemotherapy in ovarian cancer patients return to pre-treatment levels at completion: implications for immunotherapy.

Authors:  Anthony Park; Chindu Govindaraj; Sue D Xiang; Julene Halo; Michael Quinn; Karen Scalzo-Inguanti; Magdalena Plebanski
Journal:  Cancers (Basel)       Date:  2012-06-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.